日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

  Re-thinking the etiological framework of neurodegeneration

Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A., Lopez-Noguerola, J. S., Lozano Rodríguez, L., Martínez-Martínez, E., Perez-Cruz, C., Pérez-Velázquez, J., Piña, A. L., Rubio, K., García, H. P. S., Syeda, T., Vanoye-Carlo, A., Villringer, A., Winek, K., & Zille, M. (2019). Re-thinking the etiological framework of neurodegeneration. Frontiers in Neuroscience, 13:. doi:10.3389/fnins.2019.00728.

Item is

基本情報

表示: 非表示:
アイテムのパーマリンク: https://hdl.handle.net/21.11116/0000-0004-9183-3 版のパーマリンク: https://hdl.handle.net/21.11116/0000-0004-E3EE-0
資料種別: 学術論文

ファイル

表示: ファイル
非表示: ファイル
:
Castillo_2019.pdf (出版社版), 2MB
ファイルのパーマリンク:
https://hdl.handle.net/21.11116/0000-0004-9185-1
ファイル名:
Castillo_2019.pdf
説明:
-
OA-Status:
閲覧制限:
公開
MIMEタイプ / チェックサム:
application/pdf / [MD5]
技術的なメタデータ:
著作権日付:
-
著作権情報:
-
CCライセンス:
-

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Castillo, Ximena1, 2, 著者
Castro-Obregón, Susana3, 著者
Gutiérrez-Becker, Benjamin4, 著者
Gutiérrez-Ospina, Gabriel5, 著者
Karalis, Nikolaos6, 著者
Khalil, Ahmed7, 8, 9, 著者           
Lopez-Noguerola, José Sócrates10, 著者
Lozano Rodríguez, Liliana11, 著者
Martínez-Martínez, Eduardo12, 著者
Perez-Cruz, Claudia13, 著者
Pérez-Velázquez, Judith14, 15, 著者
Piña, Ana Luisa16, 著者
Rubio, Karla17, 著者
García, Héctor Pedro Salazar18, 著者
Syeda, Tauqeerunnisa13, 著者
Vanoye-Carlo, America19, 著者
Villringer, Arno7, 8, 9, 著者           
Winek, Katarzyna20, 21, 著者
Zille, Marietta22, 23, 24, 著者
所属:
1Institute of Neurobiology, National Autonomous University of Mexico, Mexico City, Mexico, ou_persistent22              
2Institute of Neurobiology, University of Puerto Rico, San Juan, PR, USA, ou_persistent22              
3Institute of Cellular Physiology, National Autonomous University of Mexico, Mexico City, Mexico, ou_persistent22              
4Laboratory for Artificial Intelligence in Medical Imaging (AI-Med), Ludwig Maximilians University Munich, Germany, ou_persistent22              
5Systems Biology Laboratory, Department of Cell Biology and Physiology, Institute of Biomedical Research and Coordination of Psychobiology and Neurosciences, National Autonomous University of Mexico, Mexico City, Mexico, ou_persistent22              
6Friedrich Miescher Institute for Biomedical Research FMI, Basel, Switzerland, ou_persistent22              
7Center for Stroke Research, Charité University Medicine Berlin, Germany, ou_persistent22              
8Berlin School of Mind and Brain, Humboldt University Berlin, Germany, ou_persistent22              
9Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society, ou_634549              
10Department of Gerontology, School of Health Sciences, Autonomous University of Hidalgo State, Pachuca, Mexico, ou_persistent22              
11Department of Biochemistry, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico, ou_persistent22              
12Cell Communication & Extracellular Vesicles Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico, ou_persistent22              
13Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Mexico City, Mexico, ou_persistent22              
14Department of Mathematics and Mechanics, Research Institute in Applied Mathematics and Systems, National Autonomous University of Mexico, Mexico City, Mexico, ou_persistent22              
15Mathematical Modeling of Biological Systems, Faculty of Mathematics, TU Munich, Germany, ou_persistent22              
16Department of Neurosurgery, Charité University Medicine Berlin, Germany, ou_persistent22              
17Lung Cancer Epigenetics, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany, ou_persistent22              
18Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany, ou_persistent22              
19Laboratorio de Neurociencias, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City, Mexico, ou_persistent22              
20Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, Israel, ou_persistent22              
21Department of Experimental Neurology, Charité University Medicine Berlin, Germany, ou_persistent22              
22Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany, ou_persistent22              
23Institute for Medical and Marine Biotechnology, University of Lübeck, Germany, ou_persistent22              
24Fraunhofer Institute for Marine Biotechnology, Lübeck, Germany, ou_persistent22              

内容説明

表示:
非表示:
キーワード: Body–brain trophism; Dysbiosis; Lifespan; Senescence; Vascular pathology
 要旨: Neurodegenerative diseases are among the leading causes of disability and death worldwide. The disease-related socioeconomic burden is expected to increase with the steadily increasing life expectancy. In spite of decades of clinical and basic research, most strategies designed to manage degenerative brain diseases are palliative. This is not surprising as neurodegeneration progresses "silently" for decades before symptoms are noticed. Importantly, conceptual models with heuristic value used to study neurodegeneration have been constructed retrospectively, based on signs and symptoms already present in affected patients; a circumstance that may confound causes and consequences. Hence, innovative, paradigm-shifting views of the etiology of these diseases are necessary to enable their timely prevention and treatment. Here, we outline four alternative views, not mutually exclusive, on different etiological paths toward neurodegeneration. First, we propose neurodegeneration as being a secondary outcome of a primary cardiovascular cause with vascular pathology disrupting the vital homeostatic interactions between the vasculature and the brain, resulting in cognitive impairment, dementia, and cerebrovascular events such as stroke. Second, we suggest that the persistence of senescent cells in neuronal circuits may favor, together with systemic metabolic diseases, neurodegeneration to occur. Third, we argue that neurodegeneration may start in response to altered body and brain trophic interactions established via the hardwire that connects peripheral targets with central neuronal structures or by means of extracellular vesicle (EV)-mediated communication. Lastly, we elaborate on how lifespan body dysbiosis may be linked to the origin of neurodegeneration. We highlight the existence of bacterial products that modulate the gut-brain axis causing neuroinflammation and neuronal dysfunction. As a concluding section, we end by recommending research avenues to investigate these etiological paths in the future. We think that this requires an integrated, interdisciplinary conceptual research approach based on the investigation of the multimodal aspects of physiology and pathophysiology. It involves utilizing proper conceptual models, experimental animal units, and identifying currently unused opportunities derived from human data. Overall, the proposed etiological paths and experimental recommendations will be important guidelines for future cross-discipline research to overcome the translational roadblock and to develop causative treatments for neurodegenerative diseases.

資料詳細

表示:
非表示:
言語: eng - English
 日付: 2019-03-312019-06-282019-07-24
 出版の状態: オンラインで出版済み
 ページ: -
 出版情報: -
 目次: -
 査読: 査読あり
 識別子(DOI, ISBNなど): DOI: 10.3389/fnins.2019.00728
PMID: 31396030
PMC: PMC6667555
その他: eCollection 2019
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示: 非表示:
Project name : -
Grant ID : 01DN18054
Funding program : -
Funding organization : German Federal Ministry of Education and Research (BMBF)

出版物 1

表示:
非表示:
出版物名: Frontiers in Neuroscience
  その他 : Front Neurosci
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: Lausanne, Switzerland : Frontiers Research Foundation
ページ: - 巻号: 13 通巻号: 728 開始・終了ページ: - 識別子(ISBN, ISSN, DOIなど): ISSN: 1662-4548
ISSN: 1662-453X
CoNE: https://pure.mpg.de/cone/journals/resource/1662-4548